FDA Authorizes Booster Shot for Children Aged 5-11 

May 18, 2022 by Alexa Hornbeck
FDA Authorizes Booster Shot for Children Aged 5-11 
This Jan. 24, 2021, photo shows a vial of the Pfizer vaccine for COVID-19 in Seattle. (AP Photo/Ted S. Warren, File)

The U.S. Food and Drug Administration amended the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine on Tuesday for children as young as 5 to receive a booster. 

Under the EUA, children aged 5-11 are now authorized for a single booster shot at least five months after completing the primary vaccine series with the Pfizer-BioNTech COVID-19 vaccine. The FDA previously authorized the use of a single booster on Jan. 3 for individuals aged 12-15.

To evaluate for effectiveness, the FDA analyzed immune response data from children aged 5-11 enrolled in a placebo-controlled trial, and gathered results from 67 study participants who received a booster dose seven to nine months after completing a two-dose primary series of the vaccine. Antibody levels against the SARS-CoV-2 virus one month after the booster dose were increased compared with before the booster dose. 

To evaluate for safety, the FDA examined results from 400 children who received a booster at least five months after the two-dose primary series and found the most common side effects were swelling at the injection site, fatigue, headache, and muscle or joint pain.

The FDA advised that while it did not hold a meeting of the Vaccines and Related Biological Products Advisory Committee regarding the recent EUA, the FDA did previously convene the committee for extensive discussion regarding booster doses, which did not indicate any need for further discussion.

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

March 27, 2024
by Dan McCue
One-Time Treatment Could Revitalize Immune Systems in the Elderly

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

March 27, 2024
by Dan McCue
Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

Five Takeaways From the Abortion Pill Case Before US Supreme Court

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

March 26, 2024
by Tom Ramstack
Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

March 26, 2024
by Dan McCue
Consumers Warned to Avoid Certain Topical Pain Relief Products 

WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed... Read More

WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed for topical use before, during or after certain cosmetic procedures. The warning came after the agency issued warning letters to six companies for marketing these products... Read More

News From The Well
scroll top